Algorae Pharmaceuticals Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:1AIHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (19.12%)
Div yield —
ROE (83.53%)
Biotechnology
Beta (5Y) (0.12)
PE TTM —
TSR TTM —
Mkt cap A$18.25M
ROIC (44.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0112
24.95%
(51.36%)
Hold 10|12|12|2|11
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
(8.27%)
0.87%
12.98%
17.08%
Revenue$M
1.424
1.406
1.418
1.389
(4.76%)
(3.12%)
(0.50%)
0.43%
Peers (US$12.53M)
Cap (US$)
PE
12.58M
—
12.11M
—
Capital
TTM
5Y
10Y
Leveragex
0.986
1.025
0.774
EBIT/Intx
1.019
1.019
0.723
Own earn%
(58.89)
(39.89)
(32.03)
Sh yield%
13.75
19.74
19.84
Owners
Insiders/Inst%
13.53
87.86
Short interest%
3.22
SBC / revenue%
2.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
21–26
$1 testx
−0.3
Incr. ROIC%
3